360 related articles for article (PubMed ID: 21612049)
21. [Emergence extensive drug resistance tuberculosis (XDR)].
Vier H; Schaberg T; Gillissen A
Pneumologie; 2007 Sep; 61(9):606-9. PubMed ID: 17729211
[TBL] [Abstract][Full Text] [Related]
22. High levels of resistance to second-line anti-tuberculosis drugs among prisoners with pulmonary tuberculosis in Georgia.
Jugheli L; Rigouts L; Shamputa IC; Bram de Rijk W; Portaels F
Int J Tuberc Lung Dis; 2008 May; 12(5):561-6. PubMed ID: 18419893
[TBL] [Abstract][Full Text] [Related]
23. Problems of multidrug- and extensively drug-resistant TB.
Drug Ther Bull; 2012 Feb; 50(2):21-4. PubMed ID: 22329954
[TBL] [Abstract][Full Text] [Related]
24. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
26. Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding.
Caminero JA
Int J Tuberc Lung Dis; 2010 Apr; 14(4):382-90. PubMed ID: 20202293
[TBL] [Abstract][Full Text] [Related]
27. Clinical and operational value of the extensively drug-resistant tuberculosis definition.
Migliori GB; Besozzi G; Girardi E; Kliiman K; Lange C; Toungoussova OS; Ferrara G; Cirillo DM; Gori A; Matteelli A; Spanevello A; Codecasa LR; Raviglione MC;
Eur Respir J; 2007 Oct; 30(4):623-6. PubMed ID: 17690121
[TBL] [Abstract][Full Text] [Related]
28. Drug-resistant tuberculosis in human immunodeficiency virus infected persons in Italy. The Italian Drug-Resistant Tuberculosis Study Group.
Angarano G; Carbonara S; Costa D; Gori A
Int J Tuberc Lung Dis; 1998 Apr; 2(4):303-11. PubMed ID: 9559401
[TBL] [Abstract][Full Text] [Related]
29. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
Abate G
Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
[TBL] [Abstract][Full Text] [Related]
30. [MDR, pre-XDR and XDR drug-resistant tuberculosis in Poland in 2000-2009].
Kozińska M; Brzostek A; Krawiecka D; Rybczyńska M; Zwolska Z; Augustynowicz-Kopeć E
Pneumonol Alergol Pol; 2011; 79(4):278-87. PubMed ID: 21678278
[TBL] [Abstract][Full Text] [Related]
31. Multidrug-resistant and extensively drug-resistant tuberculosis: a review.
Chan ED; Iseman MD
Curr Opin Infect Dis; 2008 Dec; 21(6):587-95. PubMed ID: 18978526
[TBL] [Abstract][Full Text] [Related]
32. Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Kwon YS; Kim YH; Suh GY; Chung MP; Kim H; Kwon OJ; Choi YS; Kim K; Kim J; Shim YM; Koh WJ
Clin Infect Dis; 2008 Aug; 47(4):496-502. PubMed ID: 18611154
[TBL] [Abstract][Full Text] [Related]
33. Worldwide emergence of extensively drug-resistant tuberculosis.
Shah NS; Wright A; Bai GH; Barrera L; Boulahbal F; Martín-Casabona N; Drobniewski F; Gilpin C; Havelková M; Lepe R; Lumb R; Metchock B; Portaels F; Rodrigues MF; Rüsch-Gerdes S; Van Deun A; Vincent V; Laserson K; Wells C; Cegielski JP
Emerg Infect Dis; 2007 Mar; 13(3):380-7. PubMed ID: 17552090
[TBL] [Abstract][Full Text] [Related]
34. Extensively drug-resistant Mycobacterium tuberculosis during a trend of decreasing drug resistance from 2000 through 2006 at a Medical Center in Taiwan.
Lai CC; Tan CK; Huang YT; Chou CH; Hung CC; Yang PC; Luh KT; Hsueh PR
Clin Infect Dis; 2008 Oct; 47(7):e57-63. PubMed ID: 18715157
[TBL] [Abstract][Full Text] [Related]
35. Recent advances in the diagnosis and treatment of multidrug-resistant tuberculosis.
Ahmad S; Mokaddas E
Respir Med; 2009 Dec; 103(12):1777-90. PubMed ID: 19660927
[TBL] [Abstract][Full Text] [Related]
36. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
[TBL] [Abstract][Full Text] [Related]
37. [Anti-tuberculosis drug resistance and therapeutic dead end].
Veziris N; Robert J
Med Sci (Paris); 2010 Nov; 26(11):976-80. PubMed ID: 21106180
[TBL] [Abstract][Full Text] [Related]
38. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives.
Migliori GB; Centis R; Lange C; Richardson MD; Sotgiu G
Curr Opin Pulm Med; 2010 May; 16(3):171-9. PubMed ID: 20134324
[TBL] [Abstract][Full Text] [Related]
39. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
40. Management of multidrug-resistant tuberculosis: Update 2007.
Yew WW; Leung CC
Respirology; 2008 Jan; 13(1):21-46. PubMed ID: 18197909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]